Factors related to manufacturing, distribution, public acceptance, and the severity of the pandemic will contribute more to the success of a potential COVID-19 vaccination program than the efficacy of the vaccine itself, finds a new study conducted by the...
Yale’s Saad Omer has devoted his career to studying the spread of respiratory diseases like influenza and SARS CoV-2, which causes COVID-19, and how society can increase vaccination rates.
In an interview with YaleNews, Omer, a professor at Yale School of...
Five years ago, a Yale-led partnership launched a landmark study to identify the biomarkers, or biological indictors, of autism that could help diagnose, track, and assess treatments in patients.
Since then, the Autism Biomarkers Consortium for Clinical...